Forschungsprojekte
Ergebnisse pro Seite:
10
2021 - 2030
ESPED: Erhebungseinheit für Seltene Pädiatrische Erkrankungen in Deutschland- Prof. Dr. MichaelUrschitz
2021 - 2024
A Pivotal Phase 2 Trial of Antibody Naxitamab (hu3F8) and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in High-Risk Neuroblastoma Patients with Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow- Univ.-Prof. Dr. med. JörgFaber,
- Dr. med. ArthurWingerter
2021 - 2029
INFORM – INdividualized Therapy FOr Relapsed Malignancies in Childhood- Univ.-Prof. Dr. med. JörgFaber
2021 - 2024
SIOP-HRMB is an international, prospective, phase III randomised trial in patients older than age of 3 years with ‘high-risk’ medulloblastoma- Univ.-Prof. Dr. med. JörgFaber,
- Dr. med. ArthurWingerter,
- Dr. med. AlexandraRusso
2021 - 2029
ALLTogether1 – A Treatment study protocol of the ALLTogether Consortium for children and young adults (1-45 years of age) with newly diagnosed acute lymphoblastic leukaemia (ALL)- Univ.-Prof. Dr. med. JörgFaber,
- Dr. med. ArthurWingerter,
- Dr. med. AlexandraRusso
2021 - 2025
Paediatric Hepatic International Tumour Trial (PHITT)- Dr. med. FrancescaAlt,
- Univ.-Prof. Dr. med. JörgFaber,
- Dr. med. ArthurWingerter
2021 - 2029
Molecular Data Generation and Clinical Follow-up within the International Molecular Neuropathology Registry- Univ.-Prof. Dr. med. JörgFaber